- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01031095
(A Novel Pharmacologic Regime for Elective Percutaneous Coronary Intervention) (REDUCED)
A RandomisED StUdy Comparing Standard Systemic Anticoagulation ThErapy to Low Dose Intracoronary Anticoagulation Therapy for Elective Percutaneous Coronary Intervention
The hypothesis:
Low dose intracoronary unfractionated heparin is as effective and safe as standard dose intravenous unfractionated heparin on patients with elective percutaneous coronary intervention.
연구 개요
상세 설명
Aim:
Primary objective:To evaluate the efficiency and safety of low dose intracoronary unfractioned heparin (UFH) on elective percutaneous coronary intervention (PCI).
Secondary objective:
- To evaluate the effect of low dose intracoronary UFH on myocardial ischemia after PCI.
- To evaluate the effect of low dose intracoronary UFH on bleeding complications after PCI.
- To evaluate the cost-effectivity of low dose intracoronary UFH on elective PCI
Study central:
- Bursa Postgraduate Hospital, Cardiology Clinic
Study population:
- we planned to enrol 200 patients.
- Patients will randomise in two groups (control group:100 patients, study group:100 patients)
Study works:-Write case report form for all patients
- Control for inclusion criteria
- Demographic data (age, gender)
- Height, weight, BMI and glomerular filtration rate (GFR)
- Risk factors
- laboratory data (biochemical and hematologic)
- Medication history
- Echocardiographic data
- Angiographic data
- Procedure time
- PCI data(vessel diameter, stent diameter, lesion and stent length, performed percutaneous transluminal coronary angioplasty (PTCA) or not, etc)
- Before and after procedure (activated clotting time) ACT value
- Before and after procedure troponin I (TnI) and Creatine kinase MB (CKMB) levels
- Note complication (MACE, bleeding, hematoma etc)
Note femoral compression time.
4 weeks later note the first control data.
Six months later note the second control data.
연구 유형
등록 (실제)
단계
- 3단계
연락처 및 위치
연구 장소
-
-
-
Bursa, 칠면조, 16320
- Bursa Yüksek İhtisas Eğitim Ve Araştırma Hastanesi
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- The patients; who have planned elective PCI and have had written informed consent for participation to study.
The native coronary artery;
- lesion with narrowing >=70%,
- lesion without thrombus
- no left main coronary artery (LMCA) lesion
- no chronic total occlusion lesion
Exclusion Criteria:
- Patients have allergy for acetylsalicylic acid (ASA), Clopidogrel and heparin
- Patients who performed primary PCI
- Patients with acute coronary syndrome
- Patients with have a history of myocardial infarction (MI) for two weeks
- Patients who were use UFH or low molecular weight heparin (LMWH) for 24 hours
- Patients on warfarin therapy
- Patients who have bleeding diathesis, or have high risk for bleeding.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: Low dose intracoronary heparin
Low dose intracoronary heparin: In this group elective coronary intervention was performed with low dose intracoronary Heparin
|
elective coronary intervention
|
활성 비교기: Standard treatment arm
Standard treatment arm: In this group elective coronary intervention performed with standard dose intravenous heparin
|
elective coronary intervention
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
---|---|
Major Adverse Cardiac Events
기간: 30 days
|
30 days
|
Major Adverse Cardiac Event
기간: 30 days
|
30 days
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Hasan Arı, MD, Bursa Postgraduate Hospital
간행물 및 유용한 링크
일반 간행물
- Stabile E, Nammas W, Salemme L, Sorropago G, Cioppa A, Tesorio T, Ambrosini V, Campopiano E, Popusoi G, Biondi Zoccai G, Rubino P. The CIAO (Coronary Interventions Antiplatelet-based Only) Study: a randomized study comparing standard anticoagulation regimen to absence of anticoagulation for elective percutaneous coronary intervention. J Am Coll Cardiol. 2008 Oct 14;52(16):1293-8. doi: 10.1016/j.jacc.2008.07.026.
- Ari H, Kivac E, Ari S, Emlek N, Cetinkaya S, Celiloglu N, Sarigul OY, Aydin C, Akkaya M, Koca V, Bozat T, Gurdogan M. The REDUCED (a RandomisED stUdy Comparing standard systemic anticoagulation thErapy to low Dose intracoronary anticoagulation therapy for elective percutaneous coronary intervention) trial. A novel pharmacologic regime for elective percutaneous coronary intervention. Acta Cardiol. 2014 Dec;69(6):619-27. doi: 10.1080/ac.69.6.1000004.
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- BYİEAH1
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
관상동맥 질환에 대한 임상 시험
-
Chinese Academy of Medical Sciences, Fuwai HospitalMedtronic; CCRF Consulting Co., Ltd.빼는Transradial-transfemoral Coronary Interventions 비교
-
CCRF Consulting Co., Ltd.Peking University First Hospital; Terumo Medical(shanghai) Co.,Ltd.알려지지 않은심장 또는 뇌혈관 질환 무료 요금 | Transradial-transfemoral Coronary Interventions 비교중국
-
Hospital Clinic of BarcelonaAstraZeneca완전한CTO(Chronic Total Occlusion)를 위한 PCI(Percutaneous Coronary Intervention)를 받을 예정인 환자스페인
-
Micell TechnologiesCardialysis BV; ClinLogix. LLC알려지지 않은
-
University Medical Center Groningen모병
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); US Department...완전한신장 질환 | 만성 신장 질환 | 급성 신부전 | 관상동맥(Artery); 질병
coronary intervention에 대한 임상 시험
-
Elixir Medical Corporation완전한관상동맥 질환뉴질랜드, 벨기에, 독일, 폴란드, 덴마크, 브라질
-
VA Office of Research and Development모집하지 않고 적극적으로
-
Washington University School of MedicineSt. Jude Children's Research Hospital완전한
-
University of MichiganNational Institute on Drug Abuse (NIDA)모집하지 않고 적극적으로